Bausch Health Companies Inc.: updates and filings

BHCNYSEHealthcare · Pharmaceutical Preparations

Price

$8.56

November 19, 2026Market cap $3.2B

What Ploutos Investor adds for Bausch Health Companies

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 24% since Oct 28, 2026, when the 10-Q these figures come from was filed ($6.92 then, $8.56 on Nov 19, 2026). The figures date from before that move.10-Q

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 70 daysAround Jan 29, 2027 · for Q4 2026

last Oct 28, 2026next Jan 29, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 19, 2026 latest annualOct 29, 2026 latest quarterly
  • Oct 29, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 28, 2026Results of operations
    Form8-K
  • Jul 30, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Jul 29, 2026Results of operations
    Form8-K
  • Jul 1, 2026Officer or director change, Regulation FD disclosure
    Form8-K
  • Jun 1, 2026Conflict minerals report
    FormSD
  • May 19, 2026Shareholder vote
    Form8-K
  • Apr 30, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • Apr 29, 2026Results of operations
    Form8-K
  • Apr 8, 2026Annual report to shareholdersfor the period to Dec 31, 2025
    FormARS
  • Apr 8, 2026Additional annual meeting material
    FormDEFA14A
  • Apr 8, 2026Annual meeting proxy statement
    FormDEF 14A
  • Mar 2, 2026Officer or director change
    Form8-K
  • Feb 19, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Feb 18, 2026Results of operations
    Form8-K
  • Jan 23, 2026Regulation FD disclosure
    Form8-K
  • Jan 13, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Jan 2, 2026Material agreement entered, new material financial obligation, other material events
    Form8-K
  • Dec 29, 2025Material agreement entered, new material financial obligation
    Form8-K
  • Dec 23, 2025Other material events
    Form8-K
  • Dec 12, 2025Other material events
    Form8-K
  • Dec 9, 2025Other material events
    Form8-K
  • Nov 24, 2025Other material events
    Form8-K
  • Nov 14, 2025Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 30, 2025Quarterly reportfor the period to Sep 30, 2025
    Form10-Q

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since May 22, 1996: every report, 8-K, meeting and letter. Of its other filings (1,191 in all), the newest.

The full analysis

What do Bausch Health Companies's filings show?

The filings are where every one of Bausch Health Companies's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.